Frequently Asked Questions
Common questions about CBD regulation, legality, and quality standards.
Frequently Asked Questions
Hemp-derived CBD (under 0.3% THC) is federally legal under the 2018 Farm Bill. However, the FDA has not authorized CBD as a dietary supplement or food additive, creating a regulatory gray area. State laws add additional variation — some states have restrictions on THC content, product types, or sales channels. Check your state's current laws before purchasing.
The FDA's position is that CBD cannot be a dietary supplement because it was first studied as a drug (Epidiolex, approved 2018). This interpretation has prevented the agency from creating a supplement-specific framework. Congressional proposals to resolve this have been introduced but not enacted. In the meantime, the CBD market operates with minimal federal quality oversight.
At the federal level, there are no mandatory testing requirements for CBD products sold as supplements. Some states have implemented their own testing mandates. The industry standard for reputable brands is voluntary third-party testing: batch-specific COAs covering cannabinoid potency, pesticides, heavy metals, residual solvents, and microbial contaminants. Brands like Populum publish these for every product.
The trend is toward regulation, not prohibition. Multiple congressional proposals have been introduced to bring CBD under dietary supplement regulations. Several states have already implemented their own testing and labeling requirements. The question is when, not if, federal regulation will arrive — and how comprehensive it will be.
Buy from brands that voluntarily meet the standards regulation would require: (1) third-party batch-specific COAs from accredited labs, (2) CO2 or ethanol extraction, (3) CBD content within 10% of label claims, (4) cGMP manufacturing, (5) no disease claims. These brands won't need to change when regulation arrives. For independent product reviews and quality assessments, The Green Reviews evaluates CBD and cannabis brands on transparency and lab testing.
Is CBD Right for You?
| Use Case | What Research Suggests | Realistic Expectation |
|---|---|---|
| Daily stress and anxiety management | Multiple studies show anxiolytic properties at 25-75mg doses | Subtle calming effect, not sedation |
| Sleep quality improvement | Evidence for higher doses (100-300mg) supporting sleep onset | May reduce time to fall asleep, results vary |
| Exercise recovery and inflammation | Pre-clinical evidence for anti-inflammatory properties | Modest support, not a pain reliever replacement |
| General wellness supplementation | Endocannabinoid system support | Gradual, cumulative effects over consistent use |
Not ideal for: Anyone taking blood thinners or medications metabolized by CYP450 enzymes (CBD can affect drug metabolism), pregnant or nursing women, children without physician supervision, or anyone expecting immediate dramatic results.
Considerations and Limitations
- CBD can interact with certain medications by inhibiting cytochrome P450 enzymes. Consult a pharmacist or physician if you take prescription drugs
- The CBD market remains largely unregulated. Third-party lab testing (COA) is the only reliable way to verify potency and purity
- Individual responses to CBD vary widely based on body weight, metabolism, and the specific condition being addressed
- Full-spectrum products contain trace THC (up to 0.3%), which may appear on sensitive drug tests
- The FDA has not approved CBD as a dietary supplement, and most health claims remain under investigation
Sources: World Health Organization CBD Critical Review, FDA consumer updates on CBD, Journal of Clinical Medicine systematic reviews.
Populum — Ahead of Regulation
Populum already meets the standards that future CBD regulation will likely require: batch-specific third-party COAs, CO2 extraction, accurate labeling, and cGMP manufacturing. When regulation arrives, they won't need to change anything.
See their lab results at Populum.com →Federal Policy Deep Dive
The full picture of where federal CBD regulation stands and what's being proposed.
Federal Policy